Manuka Honey Sinus Irrigation Versus Systemic Itraconazole in Allergic Fungal Rhinosinusitis: Randomised Clinical Trial for Efficacy and Safety
Clinical Otolaryngology · 2026
DOI: 10.1111/coa.70161 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Otolaryngology, 2026. Verfasst von Khalaf Hamead und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Faculty of Medicine, Minia University, Minya, Egypt. Hauptthemen laut MEDLINE: Allergic Fungal Sinusitis, Antifungal Agents, Honey, Itraconazole. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Allergic fungal rhinosinusitis (AFRS) is a persistent sinus condition caused by fungal allergies. Endoscopic sinus surgery (ESS) and postoperative systematic and local medical therapies are the most common treatment protocols. Although oral antifungals such as itraconazole are frequently utilised postoperatively, there is increasing interest in alternate therapies that exhibit fewer systemic adverse effects. Manuka honey, recognised for its powerful antibacterial, antifungal and anti‐inflammatory characteristics, is a promising alternative. The aim of this study was to assess the efficacy of Manuka honey sinus irrigation in comparison with oral itraconazole for the postoperative management of AFRS.
Methods
Thirty patients diagnosed with AFRS were recruited for the current randomised clinical trial after ESS. Patients in the two groups randomly received either oral itraconazole (Group A) or Manuka honey sinus irrigation (Group B) for 6 weeks postoperatively. Both cohorts were monitored for 6 months postoperatively.
Results
Lund–Kennedy endoscopic scores, total IgE levels and SNOT‐22 scores were significantly improved in Group B after Manuka honey sinus irrigation. Both groups had similar Lund–Mackay radiological scores and numbers of postoperative sinus infections during the follow‐up period.
Conclusions
Postoperative Manuka honey sinus irrigation is more effective than oral itraconazole for reducing symptoms and preventing the recurrence of AFRS. It is considered a promising therapeutic alternative in the postoperative management of AFRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Faculty of Medicine, Minia University, Minya, Egypt.
ORCID-Profile: Khalaf Hamead, Khaled Mohamed Abdelzaher
Zitieren
APA
Hamead, K., Ismail, M., Abdelkarim, A. A., Abdelhakim, A. A., & Abdelzaher, K. M. (2026). Manuka Honey Sinus Irrigation Versus Systemic Itraconazole in Allergic Fungal Rhinosinusitis: Randomised Clinical Trial for Efficacy and Safety. Clinical Otolaryngology. https://doi.org/10.1111/coa.70161
Vancouver
Hamead K, Ismail M, Abdelkarim AA, Abdelhakim AA, Abdelzaher KM. Manuka Honey Sinus Irrigation Versus Systemic Itraconazole in Allergic Fungal Rhinosinusitis: Randomised Clinical Trial for Efficacy and Safety. Clinical Otolaryngology. 2026. doi:10.1111/coa.70161
BibTeX
@article{Hamead2026,
author = {Hamead, Khalaf and Ismail, Mostafa and Abdelkarim, Abdelrahim A and Abdelhakim, Abdelhakim Atef and Abdelzaher, Khaled Mohamed},
title = {Manuka Honey Sinus Irrigation Versus Systemic Itraconazole in Allergic Fungal Rhinosinusitis: Randomised Clinical Trial for Efficacy and Safety},
journal = {Clinical Otolaryngology},
year = {2026},
doi = {10.1111/coa.70161}
}
EUVIMED